Status:
UNKNOWN
Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort
Lead Sponsor:
University Hospital, Angers
Conditions:
Metabolic Diseases
Sleep Apnea
Eligibility:
All Genders
18-80 years
Brief Summary
The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep a...
Eligibility Criteria
Inclusion
- informed consent
- age \> 18 years old
- suspected of metabolic syndrome
- affiliated to french social health care
Exclusion
- age \< 18 years old
- pregnancy
- no informed consent
- not eligible for the study (no MS, cancer)
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00997165
Start Date
March 1 2008
End Date
March 1 2017
Last Update
October 19 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pôle Maladies Métaboliques et Médecine Interne
Angers, France, 49993